The not-for-profit play

Although MDS Proteomics Inc. is in business to discover and develop drug candidates based on knowledge gleaned from proteomics, the company last week set up a not-for-profit organization with IBM Corp. to aggregate protein interaction data from public sources.

While it seems contradictory to give away information on which its business is based, MDS believes that it will be able to

Read the full 600 word article

User Sign In